Revolution Medicines
The Director, Market Access Analytics leads analytics and insights for US Market Access, translating payer, reimbursement, and patient access data into strategic guidance to support launch planning and commercialization readiness. This role partners with cross-functional teams to develop analytics plans, evolve KPI frameworks, and evaluate patient access performance using complex data sources. The position requires deep expertise in the US market access landscape and a track record of converting data into actionable recommendations in a fast-growing organization.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
6% above the average for this role
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Senior Director, Market Access Analytics
CSL Behring
Sr Director Market Access Strategy, Access Optimization
GSK plc
Director, Market Access Pricing & Analytics
Deciphera Pharmaceuticals
Senior Director, Field Market Access
Orca Bio
Market Access Manager
C0000159900P
Value and Access Insights Associate Director, Obesity
Amgen